针对RAS/RAF/MAPK途径进行癌症治疗:从机制到临床研究
Md Entaz Bahar1, Hyun Joon Kim2, Deok Ryong Kim3
1Department of Biochemistry and Convergence Medical Sciences and Institute of Medical Science, Gyeongsang National University, College of Medicine, Jinju, South Korea.
Signal transduction and targeted therapy
|December 17, 2023
概括
针对RAF激酶和自为RAF突变癌症提供了新的策略,解决RAF抑制剂 (RAFi) 和MEK抑制剂等当前疗法的耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 转移性癌症构成重大威胁,需要对转移和化学抵抗机制进行研究.
- 基因激活蛋白激酶 (MAPK) 途径,包括RAS-RAF-MEK-ERK信号传递,对细胞功能至关重要,并与癌症有关.
- 结合RAF抑制剂 (RAFi) 和MEK阻塞剂的RAF抑制剂是FDA批准的RAF突变癌症,但治疗耐药性是一个主要的挑战.
研究的目的:
- 审查对RAF激酶信号传递在瘤发生和对RAF抑制剂的耐药性的机制性见解.
- 探索下一代RAF抑制剂的开发.
- 讨论RAF向治疗和癌症中自的相互作用.
主要方法:
- 文献综述侧重于RAF激酶信号传递,癌症转移,化学抵抗和自.
- 分析当前和新兴的RAF抑制剂疗法.
- 探索自在治疗耐药性中的作用.
主要成果:
- RAF 激酶是MAPK信号传递的核心,控制重要细胞过程,并与癌症发展有关.
- 自是一种细胞循环过程,对癌症中对RAF抑制剂的抵抗有显著的贡献.
- 下一代RAF抑制剂正在开发中,以改善治疗结果.
结论:
- 针对RAF和自两者,为RAF突变癌症提供了一个有前途的新疗法策略.
- 了解RAF向疗法和自的功能相互作用是克服治疗耐药性的关键.
- 对下一代RAF抑制剂和组合疗法的进一步研究是有必要的.
相关概念视频
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


